On March 6, 2024, Alimera Sciences, Inc. (Alimera) entered into the Seventh Amendment (the Amendment) to its Loan and Security Agreement dated December 31, 2019, with SLR Capital Partners, LLC (SLR) as collateral agent, and the lenders party thereto, including SLR in its capacity as a lender (each a Lender and collectively, the Lenders) (as amended by the First Amendment dated as of May 1, 2020, the Second Amendment dated as of March 30, 2021, the Third Amendment dated as of February 22, 2022, the Fourth Amendment dated December 7, 2022, the Fifth Amended dated March 24, 2023 and the Sixth Amendment dated May 17, 2024, the Loan Agreement, and as further amended by the Amendment, the Amended Loan Agreement). Pursuant to the Amendment, the Lenders agreed to, among other things, increase the amount available under the facility from $67,500,000 to $72,500,000 and funded an additional term loan of $5,000,000 on March 6, 2024. The maturity date of the Amended Loan Agreement remains April 30, 2028, and the interest-only period remains in effect through April 30, 2025.

As previously disclosed, the interest-only period may be extended an additional 12 months if Alimera meets certain financial targets by April 20, 2025.